• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响颅内动脉瘤性蛛网膜下腔出血患者生存的因素:一项长期观察性队列研究。

Predictors of survival after aneurysmal subarachnoid hemorrhage: The long-term observational cohort study.

机构信息

Department of Neurosurgery and Spine Surgery, University Hospital of Essen, Hufelandstraße 55, Essen 45147, Germany.

Department of Neurosurgery and Spine Surgery, Evangelisches Krankenhaus Oldenburg, Steinweg 13, Oldenburg 26122, Germany.

出版信息

Clin Neurol Neurosurg. 2024 Dec;247:108605. doi: 10.1016/j.clineuro.2024.108605. Epub 2024 Oct 20.

DOI:10.1016/j.clineuro.2024.108605
PMID:39486277
Abstract

OBJECTIVE

Despite recent advances in neuro-intensive care, there is still considerable mortality in patients with aneurysmal subarachnoid hemorrhage (SAH). In this long-term monocentric observational cohort study, we aimed to analyze the rates, timing, and predictors of mortality after SAH.

METHODS

All consecutive SAH cases treated between January 2003 and June 2016 were included. Patients' demographic characteristics, previous medical history, SAH-related parameters, and available post-treatment follow-up data were collected and evaluated as potential mortality predictors in univariate and multivariate analyses.

RESULTS

Of 992 patients, 179 died during the initial treatment and 33 during the follow-up time reaching an overall mortality rate of 21.4 %. Of over 119 tested variables, we identified the following independent predictors in the final multivariate Cox regression analysis: age >55 years (p<0.0001); World Federation of Neurosurgical Societies (WFNS) admission grade IV or V (p=0.025); Hijdra sum score ≥15 points (p=0.003); intracranial pressure (ICP) increase (p<0.0001); and delayed cerebral ischemia (DCI) (p<0.0001). Being exposed to all five risk factors resulted in the case fatality rate of 75 % within a median survival of 14 days, compared to 2.5 % within a median of 1525 days when none of these features were present.

CONCLUSIONS

The initial impact of aneurysmal bleeding is amongst the major mortality causes after SAH. Of potentially preventable adverse events, ICP increase and DCI occurring during initial treatment also present eminent clinical relevance for patients' survival in the long-term follow-up. Further ICP and DCI management optimization might help to decrease the mortality rate after SAH.

摘要

目的

尽管神经重症监护领域取得了近期进展,但动脉瘤性蛛网膜下腔出血(SAH)患者的死亡率仍然相当高。在这项长期的单中心观察性队列研究中,我们旨在分析 SAH 后的死亡率、时间和预测因素。

方法

纳入 2003 年 1 月至 2016 年 6 月期间连续收治的所有 SAH 患者。收集患者的人口统计学特征、既往病史、SAH 相关参数和可获得的治疗后随访数据,并在单变量和多变量分析中评估其作为潜在死亡率预测因素的价值。

结果

992 例患者中,179 例在初始治疗期间死亡,33 例在随访期间死亡,总死亡率为 21.4%。在超过 119 个测试变量中,我们在最终的多变量 Cox 回归分析中确定了以下独立预测因素:年龄>55 岁(p<0.0001);世界神经外科学会联合会(WFNS)入院分级 IV 或 V 级(p=0.025);Hijdra 评分≥15 分(p=0.003);颅内压(ICP)升高(p<0.0001);和迟发性脑缺血(DCI)(p<0.0001)。如果患者存在这 5 个危险因素,则中位生存时间 14 天内的病死率为 75%,而如果这些特征均不存在,则中位生存时间 1525 天内的病死率为 2.5%。

结论

SAH 后初始出血的影响是导致患者死亡的主要原因之一。在可能预防的不良事件中,初始治疗期间发生的 ICP 升高和 DCI 对患者的长期生存也具有重要的临床意义。进一步优化 ICP 和 DCI 管理可能有助于降低 SAH 后的死亡率。

相似文献

1
Predictors of survival after aneurysmal subarachnoid hemorrhage: The long-term observational cohort study.影响颅内动脉瘤性蛛网膜下腔出血患者生存的因素:一项长期观察性队列研究。
Clin Neurol Neurosurg. 2024 Dec;247:108605. doi: 10.1016/j.clineuro.2024.108605. Epub 2024 Oct 20.
2
Intraoperative mild hypothermia for postoperative neurological deficits in intracranial aneurysm patients.颅内动脉瘤患者术中轻度低温与术后神经功能缺损
Cochrane Database Syst Rev. 2012 Feb 15(2):CD008445. doi: 10.1002/14651858.CD008445.pub2.
3
Treatment of patients with aneurysmal subarachnoid hemorrhage and multiple aneurysms: Concurrent versus delayed treatment.颅内多发动脉瘤破裂伴蛛网膜下腔出血患者的治疗:同期与分期治疗。
Clin Neurol Neurosurg. 2024 Dec;247:108647. doi: 10.1016/j.clineuro.2024.108647. Epub 2024 Nov 19.
4
Intraoperative mild hypothermia for postoperative neurological deficits in people with intracranial aneurysm.颅内动脉瘤患者术中轻度低温与术后神经功能缺损的关系
Cochrane Database Syst Rev. 2016 Mar 22;3(3):CD008445. doi: 10.1002/14651858.CD008445.pub3.
5
Corticosteroids for aneurysmal subarachnoid haemorrhage and primary intracerebral haemorrhage.用于动脉瘤性蛛网膜下腔出血和原发性脑出血的皮质类固醇。
Cochrane Database Syst Rev. 2005 Jul 20(3):CD004583. doi: 10.1002/14651858.CD004583.pub2.
6
Thrombolysis for aneurysmal subarachnoid haemorrhage.动脉瘤性蛛网膜下腔出血的溶栓治疗
Cochrane Database Syst Rev. 2025 Jan 17;1(1):CD013748. doi: 10.1002/14651858.CD013748.pub2.
7
Risk factors of short-term poor functional outcomes and long-term durability of ruptured large or giant intracranial aneurysms.大型或巨大型破裂颅内动脉瘤短期功能预后不良及长期耐久性的危险因素。
J Neurosurg. 2025 Jan 10;142(6):1776-1785. doi: 10.3171/2024.8.JNS24894. Print 2025 Jun 1.
8
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
9
Endothelin-receptor antagonists for aneurysmal subarachnoid hemorrhage: an updated meta-analysis of randomized controlled trials.用于动脉瘤性蛛网膜下腔出血的内皮素受体拮抗剂:随机对照试验的最新荟萃分析
Crit Care. 2012 Oct 18;16(5):R198. doi: 10.1186/cc11686.
10
Functional Outcome After Poor-Grade Subarachnoid Hemorrhage: A Single-Center Study and Systematic Literature Review.低级别蛛网膜下腔出血后的功能结局:一项单中心研究及系统文献综述
Neurocrit Care. 2016 Dec;25(3):338-350. doi: 10.1007/s12028-016-0305-3.

引用本文的文献

1
Clinical Predictors of Inpatient Mortality and Poor Postoperative Course After aSAH Microsurgical Clipping: A 10-Year Experience from a Peruvian Tertiary Care Center.颅内动脉瘤性蛛网膜下腔出血显微手术夹闭术后住院死亡率及术后不良病程的临床预测因素:来自秘鲁一家三级医疗中心的10年经验
J Clin Med. 2025 Jul 7;14(13):4799. doi: 10.3390/jcm14134799.